Riloha Rivas, Matilde
Warsame, Marian
Mbá Andeme, Ramona
Nsue Esidang, Salomón
Ncogo, Policarpo Ricardo
Phiri, Wonder Philip
Oki Eburi, Consuelo
Edú Maye, Corona Eyang
Menard, Didier
Legrand, Eric
Berzosa, Pedro
Garcia, Luz
Lao Seoane, Angela Katherine
Ntabangana, Spes Caritas
Ringwald, Pascal
Clinical trials referenced in this document:
Documents that mention this clinical trial
Therapeutic efficacy of artesunate-amodiaquine and artemether-lumefantrine and polymorphism in Plasmodium falciparum kelch13-propeller gene in Equatorial Guinea
https://doi.org/10.1186/s12936-021-03807-x
Funding for this research was provided by:
Bill and Melinda Gates Foundation (OPP1140599)
Agence Nationale de la Recherche (ANR-11-LABX-0024-PARAFRAP)
University of Gothenburg
Article History
Received: 3 March 2021
Accepted: 7 June 2021
First Online: 22 June 2021
Declarations
:
: The study was approved by the Ministry of Health and Social Welfare of Equatorial Guineas (No. 731–150), the Ethics Committee of the Spanish National Health Institute, Carlos III (CEI PI 57_2016-v3), and the WHO Research Ethics Review Committee (ERC.000286). The parents or guardians of the study children provided written informed consent before enrolling their children in the study.
: Not applicable.
: The authors declare that they have no competing interests.